Limits...
Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey.

Gallo M, Mannucci E, De Cosmo S, Gentile S, Candido R, De Micheli A, Di Benedetto A, Esposito K, Genovese S, Medea G, Ceriello A - BMJ Open Diabetes Res Care (2015)

Bottom Line: The results of the survey show wide agreement (>90%) by participants on the utility of the algorithms proposed, even if they do not cover all possible needs of patients with T2DM for a personalized therapeutic approach.In the online survey period and in the months after its conclusion, a relevant and durable increase in the number of unique users who visited the websites was registered, compared to the period preceding the survey.Patients with T2DM are heterogeneous, and there is interest toward accessible and easy to use personalized therapeutic algorithms.

View Article: PubMed Central - PubMed

Affiliation: Department of Oncological Endocrinology , AOU Città della Salute e della Scienza-Molinette , Turin , Italy.

ABSTRACT

Objective: In recent years increasing interest in the issue of treatment personalization for type 2 diabetes (T2DM) has emerged. This international web-based survey aimed to evaluate opinions of physicians about tailored therapeutic algorithms developed by the Italian Association of Diabetologists (AMD) and available online, and to get suggestions for future developments. Another aim of this initiative was to assess whether the online advertising and the survey would have increased the global visibility of the AMD algorithms.

Research design and methods: The web-based survey, which comprised five questions, has been available from the homepage of the web-version of the journal Diabetes Care throughout the month of December 2013, and on the AMD website between December 2013 and September 2014. Participation was totally free and responders were anonymous.

Results: Overall, 452 physicians (M=58.4%) participated in the survey. Diabetologists accounted for 76.8% of responders. The results of the survey show wide agreement (>90%) by participants on the utility of the algorithms proposed, even if they do not cover all possible needs of patients with T2DM for a personalized therapeutic approach. In the online survey period and in the months after its conclusion, a relevant and durable increase in the number of unique users who visited the websites was registered, compared to the period preceding the survey.

Conclusions: Patients with T2DM are heterogeneous, and there is interest toward accessible and easy to use personalized therapeutic algorithms. Responders opinions probably reflect the peculiar organization of diabetes care in each country.

No MeSH data available.


Related in: MedlinePlus

(A–E) Participants answers to the questions of the online survey.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4537916&req=5

BMJDRC2015000109F2: (A–E) Participants answers to the questions of the online survey.

Mentions: The algorithms were perceived as useful for one's own practice by 418 (92.5%) of responders (‘sometimes’ for 219 (48.5%) and ‘often’ for 199 (44%); figure 2A). Responses about the algorithms were very positive irrespective of specialty, Country of origin, gender, age category or number of patients seen in a typical month of respondents.


Algorithms for personalized therapy of type 2 diabetes: results of a web-based international survey.

Gallo M, Mannucci E, De Cosmo S, Gentile S, Candido R, De Micheli A, Di Benedetto A, Esposito K, Genovese S, Medea G, Ceriello A - BMJ Open Diabetes Res Care (2015)

(A–E) Participants answers to the questions of the online survey.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4537916&req=5

BMJDRC2015000109F2: (A–E) Participants answers to the questions of the online survey.
Mentions: The algorithms were perceived as useful for one's own practice by 418 (92.5%) of responders (‘sometimes’ for 219 (48.5%) and ‘often’ for 199 (44%); figure 2A). Responses about the algorithms were very positive irrespective of specialty, Country of origin, gender, age category or number of patients seen in a typical month of respondents.

Bottom Line: The results of the survey show wide agreement (>90%) by participants on the utility of the algorithms proposed, even if they do not cover all possible needs of patients with T2DM for a personalized therapeutic approach.In the online survey period and in the months after its conclusion, a relevant and durable increase in the number of unique users who visited the websites was registered, compared to the period preceding the survey.Patients with T2DM are heterogeneous, and there is interest toward accessible and easy to use personalized therapeutic algorithms.

View Article: PubMed Central - PubMed

Affiliation: Department of Oncological Endocrinology , AOU Città della Salute e della Scienza-Molinette , Turin , Italy.

ABSTRACT

Objective: In recent years increasing interest in the issue of treatment personalization for type 2 diabetes (T2DM) has emerged. This international web-based survey aimed to evaluate opinions of physicians about tailored therapeutic algorithms developed by the Italian Association of Diabetologists (AMD) and available online, and to get suggestions for future developments. Another aim of this initiative was to assess whether the online advertising and the survey would have increased the global visibility of the AMD algorithms.

Research design and methods: The web-based survey, which comprised five questions, has been available from the homepage of the web-version of the journal Diabetes Care throughout the month of December 2013, and on the AMD website between December 2013 and September 2014. Participation was totally free and responders were anonymous.

Results: Overall, 452 physicians (M=58.4%) participated in the survey. Diabetologists accounted for 76.8% of responders. The results of the survey show wide agreement (>90%) by participants on the utility of the algorithms proposed, even if they do not cover all possible needs of patients with T2DM for a personalized therapeutic approach. In the online survey period and in the months after its conclusion, a relevant and durable increase in the number of unique users who visited the websites was registered, compared to the period preceding the survey.

Conclusions: Patients with T2DM are heterogeneous, and there is interest toward accessible and easy to use personalized therapeutic algorithms. Responders opinions probably reflect the peculiar organization of diabetes care in each country.

No MeSH data available.


Related in: MedlinePlus